Triumph Capital Management Makes New Investment in BlackRock Capital Allocation Term Trust $BCAT

Triumph Capital Management purchased a new position in BlackRock Capital Allocation Term Trust (NYSE:BCAT) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 43,443 shares of the company’s stock, valued at approximately $692,000.

Other institutional investors have also added to or reduced their stakes in the company. Geneos Wealth Management Inc. raised its holdings in shares of BlackRock Capital Allocation Term Trust by 341.7% during the 2nd quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company’s stock worth $31,000 after buying an additional 1,582 shares in the last quarter. McIlrath & Eck LLC lifted its stake in BlackRock Capital Allocation Term Trust by 169.6% in the 1st quarter. McIlrath & Eck LLC now owns 3,130 shares of the company’s stock valued at $44,000 after purchasing an additional 1,969 shares during the last quarter. Parallel Advisors LLC bought a new position in BlackRock Capital Allocation Term Trust in the 3rd quarter valued at approximately $47,000. Brown Brothers Harriman & Co. boosted its position in BlackRock Capital Allocation Term Trust by 450.0% in the third quarter. Brown Brothers Harriman & Co. now owns 5,500 shares of the company’s stock valued at $81,000 after buying an additional 4,500 shares in the last quarter. Finally, Global Retirement Partners LLC acquired a new stake in BlackRock Capital Allocation Term Trust in the second quarter valued at approximately $115,000. 36.12% of the stock is currently owned by institutional investors and hedge funds.

BlackRock Capital Allocation Term Trust Stock Down 1.0%

NYSE BCAT opened at $15.82 on Wednesday. The firm’s fifty day moving average price is $15.81 and its two-hundred day moving average price is $15.36. BlackRock Capital Allocation Term Trust has a fifty-two week low of $13.73 and a fifty-two week high of $16.20.

BlackRock Capital Allocation Term Trust Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Wednesday, September 30th. Investors of record on Tuesday, September 15th will be given a dividend of $0.2542 per share. The ex-dividend date is Tuesday, September 15th. This represents a c) dividend on an annualized basis and a yield of 19.3%.

BlackRock Capital Allocation Term Trust Company Profile

BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.

BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.